SWAS

IN:CO:SWASTIKA

Swastika

  • Stock

INR

Last Close

170.75

25/11 09:24

Market Cap

2.33B

Beta: -

Volume Today

23.98K

Avg: -

Company Overview

Metric
Company NameSwastika Investmart LimitedIPO Watch
SymbolSWASTIKA
MSH IDIN:CO:SWASTIKAIN:IPOWATCH
MarketSTOCKSPRIVATE
SectorFinancial ServicesFinancial Services & Finance
IndustryInvestment - Banking & Investment ServicesInvestment Services
CountryININ
Stage
Employee Count658
Websiteswastika.co.inipowatch.in
LinkedInswastika-investmart-limited
Founders

Market Metrics

Metric
Market Cap27.56M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue13.54M
Revenue (LTM)
Revenue (NTM)
Gross Profit7.94M
EBITDA2.35M
Operating Income2.20M
Net Income1.45M
EPS0.49
Diluted EPS0.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.47
Operating Profit Margin0.35
EBITDA Margin0.17
Net Profit Margin0.14
Return on Equity0.30
Return on Assets0.05
Return on Capital Employed0.23

Valuation Multiples

Metric
P/E Ratio18.33
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio2.75
EV Multiple21.30

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding6.60
Operating Cycle96.22
Cash Conversion Cycle96.22
Asset Turnover0.35

Cash Flow Metrics

Metric
Operating Cash Flow-1.42M
Free Cash Flow-1.58M
Cash Flow to Debt0.65
Operating Cash Flow/Sales0.10
Free Cash Flow Yield0.05

Balance Sheet Metrics

Metric
Cash & Equivalents27.28M
Accounts Receivable-856.83K
Inventory140.89K
Goodwill
Debt to Capitalization0.26
Debt to Assets
Current Ratio
Quick Ratio1.94

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue